Copeland Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Copeland Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6	Closed	-$3.49K	–	244
2024 Q1	$3.49K	Hold	6	–	–	﹤0.01%	241
2023 Q4	$3.19K	Hold	6	–	–	﹤0.01%	242
2023 Q3	$3.04K	Hold	6	–	–	﹤0.01%	248
2023 Q2	$3.13K	Hold	6	–	–	﹤0.01%	267
2023 Q1	$3K	Hold	6	–	–	﹤0.01%	247
2022 Q4	$3K	Hold	6	–	–	﹤0.01%	251
2022 Q3	$3K	Hold	6	–	–	﹤0.01%	235
2022 Q2	$3K	Hold	6	–	–	﹤0.01%	237
2022 Q1	$4K	Hold	6	–	–	﹤0.01%	226
2021 Q4	$4K	Hold	6	–	–	﹤0.01%	229
2021 Q3	$3K	Hold	6	–	–	﹤0.01%	248
2021 Q2	$3K	Hold	6	–	–	﹤0.01%	243
2021 Q1	$3K	Hold	6	–	–	﹤0.01%	240
2020 Q4	$3K	Hold	6	–	–	﹤0.01%	232
2020 Q3	$3K	Hold	6	–	–	﹤0.01%	211
2020 Q2	$2K	Buy	+6	New	+$2.01K	﹤0.01%	237

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Copeland Capital Management's TMO Position: Q2 2024 in Review

Copeland Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 6 shares — an estimated $3.49K sold.

Copeland Capital Management first reported a position in TMO in Q2 2020 and held it in 16 quarters. The position peaked at $4K in Q1 2022. 2,548 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

Copeland Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
Copeland Capital Management sold 6 Thermo Fisher Scientific shares in Q2 2024, an estimated $3.49K.
Copeland Capital Management first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 16 quarters.
Copeland Capital Management's Thermo Fisher Scientific position peaked at $4K in Q1 2022.
2,548 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Copeland Capital Management's 13F filing for Q2 2024, filed 26 Jul 2024.